메뉴 건너뛰기




Volumn 51, Issue 1, 2011, Pages 1-16

Retinopathy of prematurity care: Screening to vitrectomy

(2)  Faia, Lisa J a   Trese, Michael T a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; PIGMENT EPITHELIUM DERIVED FACTOR; STEROID; SURFACTANT; VASCULOTROPIN INHIBITOR;

EID: 78650845389     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3182011033     Document Type: Article
Times cited : (8)

References (83)
  • 1
    • 0000473767 scopus 로고
    • Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report
    • Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report. Am J Ophthalmol. 1942;25:203-204.
    • (1942) Am J Ophthalmol , vol.25 , pp. 203-204
    • Terry, T.L.1
  • 3
    • 0025064573 scopus 로고
    • Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Arch Ophthalmol. 1990;108:1408-1416.
    • (1990) Arch Ophthalmol , vol.108 , pp. 1408-1416
  • 4
    • 0345189363 scopus 로고    scopus 로고
    • Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial
    • Early Treatment for Retinopathy of Prematurity Cooperative Group
    • Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003; 121:1684-1694.
    • (2003) Arch Ophthalmol , vol.121 , pp. 1684-1694
  • 5
    • 0026063352 scopus 로고
    • Incidence and early course of retinopathy of prematurity
    • Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-1640.
    • (1991) Ophthalmology , vol.98 , pp. 1628-1640
    • Palmer, E.A.1    Flynn, J.T.2    Hardy, R.J.3
  • 6
    • 0027446536 scopus 로고
    • Prognostic factors in the natural course of retinopathy of prematurity
    • Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology. 1993;100:230-237.
    • (1993) Ophthalmology , vol.100 , pp. 230-237
    • Schaffer, D.B.1    Palmer, E.A.2    Plotsky, D.F.3
  • 7
    • 17244381522 scopus 로고    scopus 로고
    • Final results of the early treatment for retinopathy of prematurity randomized trial
    • Early Treatment for Retinopathy of Prematurity Cooperative Group
    • Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity randomized trial. Trans Am Ophthalmol Soc. 2004;102:233-248.
    • (2004) Trans Am Ophthalmol Soc , vol.102 , pp. 233-248
    • Good, W.V.1
  • 8
    • 0033192681 scopus 로고    scopus 로고
    • Current incidence of retinopathy of prematurity, 1989-97
    • Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-97. Pediatrics. 1999;104:e26.
    • (1999) Pediatrics , vol.104
    • Hussain, N.1    Clive, J.2    Bhandari, V.3
  • 9
    • 0019385408 scopus 로고
    • Retinopathy of prematurity: An estimate of vision loss in the United States-1979
    • Phelps DL. Retinopathy of prematurity: an estimate of vision loss in the United States-1979. Pediatrics. 1981;67:924-926.
    • (1981) Pediatrics , vol.67 , pp. 924-926
    • Phelps, D.L.1
  • 10
    • 0024969219 scopus 로고
    • Outcomes of extremely-low-birth-weight infants between 1982 and 1988
    • Hack M, Fanaroff AA. Outcomes of extremely-low-birth-weight infants between 1982 and 1988. N Engl J Med. 1989;321:1642-1647.
    • (1989) N Engl J Med , vol.321 , pp. 1642-1647
    • Hack, M.1    Fanaroff, A.A.2
  • 11
    • 0034104006 scopus 로고    scopus 로고
    • Severe retinopathy of prematurity and its association with different rates of survival in infants less than 1251 g birth weight
    • Vyas J, Field D, Draper ES, et al. Severe retinopathy of prematurity and its association with different rates of survival in infants less than 1251 g birth weight. Arch Dis Child Fetal Neonatal Ed. 2000;82:F145-F149.
    • (2000) Arch Dis Child Fetal Neonatal Ed , vol.82
    • Vyas, J.1    Field, D.2    Draper, E.S.3
  • 12
    • 0034895253 scopus 로고    scopus 로고
    • Reduced incidence of retinopathy of prematurity
    • Rowlands E, Ionides ACW, Chinn S, et al. Reduced incidence of retinopathy of prematurity. Br J Ophthalmol. 2001;85:933-935.
    • (2001) Br J Ophthalmol , vol.85 , pp. 933-935
    • Rowlands, E.1    Acw, I.2    Chinn, S.3
  • 13
    • 0029888523 scopus 로고    scopus 로고
    • Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment
    • Pennefather PM, Tin W, Clarke MP, et al. Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment. Br J Ophthalmol. 1996;80:420-424.
    • (1996) Br J Ophthalmol , vol.80 , pp. 420-424
    • Pennefather, P.M.1    Tin, W.2    Clarke, M.P.3
  • 14
    • 0033071781 scopus 로고    scopus 로고
    • The decreasing incidence and severity of retinopathy of prematurity
    • Bullard SR, Donahue SP, Feman SS, et al. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS. 1999;3:46-52.
    • (1999) J AAPOS , vol.3 , pp. 46-52
    • Bullard, S.R.1    Donahue, S.P.2    Feman, S.S.3
  • 15
    • 0016704918 scopus 로고
    • Purification of a basic fibroblast growth factor from bovine pituitary
    • Gospodarowicz D. Purification of a basic fibroblast growth factor from bovine pituitary. J Biol Chem. 1975;250:2505-2510.
    • (1975) J Biol Chem , vol.250 , pp. 2505-2510
    • Gospodarowicz, D.1
  • 16
    • 0022501030 scopus 로고
    • Transforming growth factor alpha: A more potent angiogenic mediator than epidermal growth factor
    • Schreiber AB, Winkler ME, Derynk R. Transforming growth factor alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986;232: 1250-1253.
    • (1986) Science , vol.232 , pp. 1250-1253
    • Schreiber, A.B.1    Winkler, M.E.2    Derynk, R.3
  • 17
    • 0013624595 scopus 로고
    • Tumor necrosis factor alpha, a potent inhibitor of endothelial cell growth in vitro is angiogenic in vivo
    • Frater-Schroder M, Risau W, Hallman R, et al. Tumor necrosis factor alpha, a potent inhibitor of endothelial cell growth in vitro is angiogenic in vivo. Proc Natl Acad Sci U S A. 1987;84:5277-5281.
    • (1987) Proc Natl Acad Sci U S A , vol.84 , pp. 5277-5281
    • Frater-Schroder, M.1    Risau, W.2    Hallman, R.3
  • 18
    • 0026485002 scopus 로고
    • Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
    • Shweki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;358:843-845.
    • (1992) Nature , vol.358 , pp. 843-845
    • Shweki, D.1    Itin, A.2    Soffer, D.3
  • 19
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
    • (1994) N Engl J Med , vol.331 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3
  • 20
    • 0028815295 scopus 로고
    • Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
    • Pierce EA, Avery RL, Foley ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995;92:905-909.
    • (1995) Proc Natl Acad Sci U S A , vol.92 , pp. 905-909
    • Pierce, E.A.1    Avery, R.L.2    Foley, E.D.3
  • 21
    • 0029816808 scopus 로고    scopus 로고
    • Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
    • Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996;114: 1219-1228.
    • (1996) Arch Ophthalmol , vol.114 , pp. 1219-1228
    • Pierce, E.A.1    Foley, E.D.2    Smith, L.E.3
  • 22
    • 0028803509 scopus 로고
    • Vascular endothelial growth factor acts as a survival factor for newly reformed retinal vessels and implications for retinopathy of prematurity
    • Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly reformed retinal vessels and implications for retinopathy of prematurity. Nat Med. 1995;10:1025-1028.
    • (1995) Nat Med , vol.10 , pp. 1025-1028
    • Alon, T.1    Hemo, I.2    Itin, A.3
  • 23
  • 25
    • 0001762988 scopus 로고
    • Studies on retinopathy of prematurity: III. Cryocautery for retinopathy of prematurity
    • Yamashita Y. Studies on retinopathy of prematurity: III. Cryocautery for retinopathy of prematurity. Jpn J Ophthalmol. 1972;26:385-393.
    • (1972) Jpn J Ophthalmol , vol.26 , pp. 385-393
    • Yamashita, Y.1
  • 26
    • 78650801196 scopus 로고
    • Pathologic features of clinical stages of retinopathy of prematurity
    • Flynn JT, Tasman WS, eds. New York: Springer-Verlag
    • Foos RY. Pathologic features of clinical stages of retinopathy of prematurity. In: Flynn JT, Tasman WS, eds. Retinopathy of Prematurity. New York: Springer-Verlag; 1992: 23-36.
    • (1992) Retinopathy of Prematurity , pp. 23-36
    • Foos, R.Y.1
  • 27
    • 0014783541 scopus 로고
    • Retinal angiogenesis in the human embryo
    • Ashton N. Retinal angiogenesis in the human embryo. Br Med Bull. 1970;26:103-106.
    • (1970) Br Med Bull , vol.26 , pp. 103-106
    • Ashton, N.1
  • 28
    • 1942465884 scopus 로고
    • An international classification of retinopathy of prematurity
    • Committee for the Classification of Retinopathy of Prematurity
    • Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;106:471-479.
    • (1984) Arch Ophthalmol , vol.106 , pp. 471-479
  • 29
    • 0023273487 scopus 로고
    • An international classification of retinopathy of prematurity. II. The classification of retinal detachment
    • International Committee for the Classification of the Late Stages of Retinopathy of Prematurity
    • International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. Arch Ophthalmol. 1987;105:906-912.
    • (1987) Arch Ophthalmol , vol.105 , pp. 906-912
  • 30
    • 0023914308 scopus 로고
    • Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol. 1988;106:471-479.
    • (1988) Arch Ophthalmol , vol.106 , pp. 471-479
  • 31
    • 0027474498 scopus 로고
    • Multicenter trial of cryotherapy for retinopathy of prematurity: 3 year outcome-structure and function
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: 3 year outcome-structure and function. Arch Ophthalmol. 1993;111:339-344.
    • (1993) Arch Ophthalmol , vol.111 , pp. 339-344
  • 32
    • 0028307405 scopus 로고
    • The natural ocular outcome of premature birth and reinopathy. Status at 1 year
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and reinopathy. Status at 1 year. Arch Ophthalmol. 1994;112:903-912.
    • (1994) Arch Ophthalmol , vol.112 , pp. 903-912
  • 33
    • 43149121357 scopus 로고    scopus 로고
    • The photographic screening for retinopathy of prematurity study: Primary outcomes
    • The Photographic Screening for Retinopathy of Prematurity Cooperative Group
    • The Photographic Screening for Retinopathy of Prematurity Cooperative Group. The photographic screening for retinopathy of prematurity study: primary outcomes. Retina. 2008;28:S47-S54.
    • (2008) Retina , vol.28
  • 34
    • 0242379795 scopus 로고
    • Guidelines for follow-up of retinopathy of prematurity
    • Flynn JT, Tasman W, eds. New York: Springer-Verlag
    • Schaffer DB, Tung B, Hardy RJ. Guidelines for follow-up of retinopathy of prematurity. In: Flynn JT, Tasman W, eds. Retinopathy of Prematurity: A Clinician's Guide. New York: Springer-Verlag; 1992:45-53.
    • (1992) Retinopathy of Prematurity: A Clinician's Guide , pp. 45-53
    • Schaffer, D.B.1    Tung, B.2    Hardy, R.J.3
  • 35
    • 0033745291 scopus 로고    scopus 로고
    • Commentary on guidelines for screening for retinopathy of prematurity
    • Ells A, Hindle W. Commentary on guidelines for screening for retinopathy of prematurity. Can J Ophthalmol. 2000;35:253-254.
    • (2000) Can J Ophthalmol , vol.35 , pp. 253-254
    • Ells, A.1    Hindle, W.2
  • 36
    • 0031082553 scopus 로고    scopus 로고
    • Outcome-based management of retinopathy of prematurity
    • Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Hardy RJ, Palmer EA, Schaffer DB, et al; Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group. Outcome-based management of retinopathy of prematurity. J AAPOS. 1997;1:46-54.
    • (1997) J AAPOS , vol.1 , pp. 46-54
    • Hardy, R.J.1    Palmer, E.A.2    Schaffer, D.B.3
  • 37
    • 65249169460 scopus 로고    scopus 로고
    • Cost-utility analysis of screening and laser treatment of retinopathy of prematurity
    • Dunbar JA, Hsu V, Christensen M, et al. Cost-utility analysis of screening and laser treatment of retinopathy of prematurity. J AAPOS. 2009;13:186-190.
    • (2009) J AAPOS , vol.13 , pp. 186-190
    • Dunbar, J.A.1    Hsu, V.2    Christensen, M.3
  • 38
    • 78650820767 scopus 로고    scopus 로고
    • Survey: Physicians being driven away from ROP treatment
    • Accessed on: May 15, 2008
    • Survey: physicians being driven away from ROP treatment. Ocular Surgery News Web site. http://www.osnsupersite.com/view.asp?rID=18018. Accessed on: May 15, 2008.
    • Ocular Surgery News Web Site
  • 39
    • 66949171759 scopus 로고    scopus 로고
    • Retinopathy of prematurity malpractice claims: The ophthalmic mutual insurance company experience
    • Day S, Menke AM, Abbott RL. Retinopathy of prematurity malpractice claims: the ophthalmic mutual insurance company experience. Arch Ophthalmol. 2009; 127:794-798.
    • (2009) Arch Ophthalmol , vol.127 , pp. 794-798
    • Day, S.1    Menke, A.M.2    Abbott, R.L.3
  • 40
    • 48649096117 scopus 로고    scopus 로고
    • Malpractice and the quality of care in retinopathy of prematurity (an American Ophthalmological Society thesis)
    • Reynolds JD. Malpractice and the quality of care in retinopathy of prematurity (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105: 461-480.
    • (2007) Trans Am Ophthalmol Soc , vol.105 , pp. 461-480
    • Reynolds, J.D.1
  • 41
    • 0242317878 scopus 로고    scopus 로고
    • Telemedicine approach to screening for severe retinopathy of prematurity-a pilot study
    • Ells AL, Holmes JM, Astle WF, et al. Telemedicine approach to screening for severe retinopathy of prematurity-a pilot study. Ophthalmology. 2003;110:2113-2117.
    • (2003) Ophthalmology , vol.110 , pp. 2113-2117
    • Ells, A.L.1    Holmes, J.M.2    Astle, W.F.3
  • 42
    • 0033652453 scopus 로고    scopus 로고
    • Risk factors associated with agerelated macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Age-Related Eye Disease Study Research Group
    • Age-Related Eye Disease Study Research Group
    • Age-Related Eye Disease Study Research Group. Risk factors associated with agerelated macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Age-Related Eye Disease Study Research Group. Ophthalmology. 2000;107:2224-2232.
    • (2000) Ophthalmology , vol.107 , pp. 2224-2232
  • 43
    • 0024543720 scopus 로고
    • The validity and reliability of photographic documentation of proliferative vitreoretinopathy
    • Azen SP, Irvine AR, Davis MD, et al. The validity and reliability of photographic documentation of proliferative vitreoretinopathy. Ophthalmology. 1989;96: 352-357.
    • (1989) Ophthalmology , vol.96 , pp. 352-357
    • Azen, S.P.1    Irvine, A.R.2    Davis, M.D.3
  • 44
    • 0027322133 scopus 로고
    • Screening for diabetic retinopathy. The wide-angle retinal camera
    • Pugh JA, Jacobson JM, Van HeuvenWA, et al. Screening for diabetic retinopathy. The wide-angle retinal camera. Diabetes Care. 1993;16:889-895.
    • (1993) Diabetes Care , vol.16 , pp. 889-895
    • Pugh, J.A.1    Jacobson, J.M.2    Van Heuven, W.A.3
  • 45
    • 22844447612 scopus 로고    scopus 로고
    • The international classification of retinopathy of prematurity revisited
    • An International Committee for the Classification of Retinopathy of Prematurity
    • An International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991-999.
    • (2005) Arch Ophthalmol , vol.123 , pp. 991-999
  • 46
    • 0017256102 scopus 로고
    • Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasias (type 1) (in Japanese)
    • Morizane H. Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasias (type 1) (in Japanese). Nippon Ganka Gakkai Zasshi. 1976;80:54-61.
    • (1976) Nippon Ganka Gakkai Zasshi , vol.80 , pp. 54-61
    • Morizane, H.1
  • 47
    • 34247184809 scopus 로고    scopus 로고
    • Current understanding and management of retinopathy of prematurity
    • Quiram PA, Capone A Jr. Current understanding and management of retinopathy of prematurity. Curr Opin Ophthalmol. 2007;18:228-234.
    • (2007) Curr Opin Ophthalmol , vol.18 , pp. 228-234
    • Quiram, P.A.1    Capone Jr., A.2
  • 48
    • 78650832595 scopus 로고    scopus 로고
    • Viterous VEGF levels in infants with stage 4 or 5 ROP
    • Sonmez K, Drenser KA, Capone A Jr, et al. Viterous VEGF levels in infants with stage 4 or 5 ROP. Retina. 2008;15:1065-1070.
    • (2008) Retina , vol.15 , pp. 1065-1070
    • Sonmez, K.1    Drenser, K.A.2    Capone Jr., A.3
  • 49
    • 0034905430 scopus 로고    scopus 로고
    • Multicenter trial of cryotherapy for retinopathy of prematurity: Ophthalmological outcomes at 10 years
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol. 2001;119:1110-1118.
    • (2001) Arch Ophthalmol , vol.119 , pp. 1110-1118
  • 50
    • 0034899683 scopus 로고    scopus 로고
    • Effect of retinal ablative therapy for threshold retinopathy of prematurity: Results of Goldmann perimetry at the age of 10 years
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Effect of retinal ablative therapy for threshold retinopathy of prematurity: results of Goldmann perimetry at the age of 10 years. Arch Ophthalmol. 2001;119:1120-1125.
    • (2001) Arch Ophthalmol , vol.119 , pp. 1120-1125
  • 51
    • 0034899587 scopus 로고    scopus 로고
    • Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity. Arch Ophthalmol. 2001;119:1129-1133.
    • (2001) Arch Ophthalmol , vol.119 , pp. 1129-1133
  • 52
    • 0034080837 scopus 로고    scopus 로고
    • A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity
    • Banach MJ, Ferrone PJ, Trese MT. A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology. 2000;107:324-328.
    • (2000) Ophthalmology , vol.107 , pp. 324-328
    • Banach, M.J.1    Ferrone, P.J.2    Trese, M.T.3
  • 53
    • 0034111538 scopus 로고    scopus 로고
    • Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity
    • Lambert SR, Capone A Jr, Cingle KA, et al. Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity. Am J Ophthalmol. 2000; 129:585-591.
    • (2000) Am J Ophthalmol , vol.129 , pp. 585-591
    • Lambert, S.R.1    Capone Jr., A.2    Cingle, K.A.3
  • 54
    • 0035066405 scopus 로고    scopus 로고
    • Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity
    • Kaiser RS, Trese MT. Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch Ophthalmol. 2001;119: 615-617.
    • (2001) Arch Ophthalmol , vol.119 , pp. 615-617
    • Kaiser, R.S.1    Trese, M.T.2
  • 55
    • 0034961269 scopus 로고    scopus 로고
    • Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: Seven-year outcome
    • Shalev B, Farr A, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol. 2001;132:76-80.
    • (2001) Am J Ophthalmol , vol.132 , pp. 76-80
    • Shalev, B.1    Farr, A.2    Repka, M.X.3
  • 56
    • 0031757547 scopus 로고    scopus 로고
    • Three year visual outcome for treated stage 3 retinopathy of prematurity: Cryotherapy versus laser
    • Pearce IA, Pennie FC, Gannon LM, et al. Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser. Br J Ophthalmol. 1998;82: 1254-1259.
    • (1998) Br J Ophthalmol , vol.82 , pp. 1254-1259
    • Pearce, I.A.1    Pennie, F.C.2    Gannon, L.M.3
  • 57
    • 0031755510 scopus 로고    scopus 로고
    • Longer term visual outcome of eyes with retinopathy treated with cryotherapy or diode laser
    • O'Keefe M, O'Reilly J, Lanigan B. Longer term visual outcome of eyes with retinopathy treated with cryotherapy or diode laser. Br J Ophthalmol. 1998;82: 1246-1248.
    • (1998) Br J Ophthalmol , vol.82 , pp. 1246-1248
    • O'Keefe, M.1    O'Reilly, J.2    Lanigan, B.3
  • 58
    • 0034863049 scopus 로고    scopus 로고
    • Outcomes after laser therapy for threshold retinopathy of prematurity
    • Foroozan R, Connolly BP, Tasman WS. Outcomes after laser therapy for threshold retinopathy of prematurity. Ophthalmology. 2001;108:1644-1646.
    • (2001) Ophthalmology , vol.108 , pp. 1644-1646
    • Foroozan, R.1    Connolly, B.P.2    Tasman, W.S.3
  • 59
    • 0031732788 scopus 로고    scopus 로고
    • A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity
    • Connolly BP, McNamara JA, Sharma S, et al. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology. 1998;105:1628-1631.
    • (1998) Ophthalmology , vol.105 , pp. 1628-1631
    • Connolly, B.P.1    McNamara, J.A.2    Sharma, S.3
  • 60
    • 0034065769 scopus 로고    scopus 로고
    • Diode laser ablation for threshold retinopathy of prematurity. Short-term structural outcome
    • DeJonge MH, Ferrone PJ, Trese MT. Diode laser ablation for threshold retinopathy of prematurity. Short-term structural outcome. Arch Ophthalmol. 2000;118: 365-367.
    • (2000) Arch Ophthalmol , vol.118 , pp. 365-367
    • Dejonge, M.H.1    Ferrone, P.J.2    Trese, M.T.3
  • 61
    • 0027519843 scopus 로고
    • Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity
    • Capone A Jr, Diaz-Rohena R, Sternberg P Jr, et al. Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity. Am J Ophthalmol. 1993;116: 444-450.
    • (1993) Am J Ophthalmol , vol.116 , pp. 444-450
    • Capone Jr., A.1    Diaz-Rohena, R.2    Sternberg Jr., P.3
  • 62
    • 0033675005 scopus 로고    scopus 로고
    • Diode laser treatment of posterior retinopathy of prematurity
    • Axer-Siegel R, Snir M, Cotlear D, et al. Diode laser treatment of posterior retinopathy of prematurity. Br J Ophthalmol. 2000;84:1383-1386.
    • (2000) Br J Ophthalmol , vol.84 , pp. 1383-1386
    • Axer-Siegel, R.1    Snir, M.2    Cotlear, D.3
  • 63
    • 0025091975 scopus 로고
    • Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Arch Ophthalmol. 1990;108:195-204.
    • (1990) Arch Ophthalmol , vol.108 , pp. 195-204
  • 64
    • 0027317130 scopus 로고
    • Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group
    • Reynolds J, Dobson V, Quinn GE, et al. Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1993;111: 1050-1056.
    • (1993) Arch Ophthalmol , vol.111 , pp. 1050-1056
    • Reynolds, J.1    Dobson, V.2    Quinn, G.E.3
  • 65
    • 0029736857 scopus 로고    scopus 로고
    • Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome
    • Gilbert WS, Quinn GE, Dobson V, et al. Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome. Arch Ophthalmol. 1996;114:1085-1091.
    • (1996) Arch Ophthalmol , vol.114 , pp. 1085-1091
    • Gilbert, W.S.1    Quinn, G.E.2    Dobson, V.3
  • 66
    • 0028089267 scopus 로고
    • Scleral buckling for retinopathy of prematurity
    • Trese MT. Scleral buckling for retinopathy of prematurity. Ophthalmology. 1994;101:23-26.
    • (1994) Ophthalmology , vol.101 , pp. 23-26
    • Trese, M.T.1
  • 67
    • 0025371435 scopus 로고
    • Scleral buckling in stages 4B and 5 retinopathy of prematurity
    • Greven C, Tasman W. Scleral buckling in stages 4B and 5 retinopathy of prematurity. Ophthalmology. 1990;97:817-820.
    • (1990) Ophthalmology , vol.97 , pp. 817-820
    • Greven, C.1    Tasman, W.2
  • 68
    • 0031807063 scopus 로고    scopus 로고
    • Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity
    • Trese MT, Droste PJ. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology. 1998;105:992-997.
    • (1998) Ophthalmology , vol.105 , pp. 992-997
    • Trese, M.T.1    Droste, P.J.2
  • 69
    • 0034759031 scopus 로고    scopus 로고
    • Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments
    • Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology. 2001;108: 2068-2070.
    • (2001) Ophthalmology , vol.108 , pp. 2068-2070
    • Capone Jr., A.1    Trese, M.T.2
  • 70
    • 9644278080 scopus 로고    scopus 로고
    • Lens-sparing vitrectomy for stage 4 retinopathy of prematurity
    • Hubbard GB, Cherwick DH, Burian G. Lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Ophthalmology. 2004;111:2274-2277.
    • (2004) Ophthalmology , vol.111 , pp. 2274-2277
    • Hubbard, G.B.1    Cherwick, D.H.2    Burian, G.3
  • 71
    • 9644283039 scopus 로고    scopus 로고
    • Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity
    • Prenner JL, Capone A Jr, Trese MT. Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology. 2004;111:2271-2273.
    • (2004) Ophthalmology , vol.111 , pp. 2271-2273
    • Prenner, J.L.1    Capone Jr., A.2    Trese, M.T.3
  • 72
    • 0031797858 scopus 로고    scopus 로고
    • Refractive changes associated with scleral buckling and division in retinopathy of prematurity
    • Chow DR, Ferrone PJ, Trese MT. Refractive changes associated with scleral buckling and division in retinopathy of prematurity. Arch Ophthalmol. 1998;116: 1446-1448.
    • (1998) Arch Ophthalmol , vol.116 , pp. 1446-1448
    • Chow, D.R.1    Ferrone, P.J.2    Trese, M.T.3
  • 73
    • 6344250444 scopus 로고    scopus 로고
    • Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity
    • Hartnett ME, Maguluri S, ThompsonHW, et al. Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Retina. 2004;24:753-757.
    • (2004) Retina , vol.24 , pp. 753-757
    • Hartnett, M.E.1    Maguluri, S.2    Thompson, H.W.3
  • 74
    • 85027923955 scopus 로고    scopus 로고
    • Ab interno incision for pediatric vitreoretinal surgery
    • Ho LY, Ranchod TM, Drenser KA, et al. Ab interno incision for pediatric vitreoretinal surgery. Retina. 2010;30:1542-1543.
    • (2010) Retina , vol.30 , pp. 1542-1543
    • Ho, L.Y.1    Ranchod, T.M.2    Drenser, K.A.3
  • 75
    • 0030013610 scopus 로고    scopus 로고
    • Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
    • Robinson GS, Pierce EA, Rook SL, et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A. 1996;93:4851-4856.
    • (1996) Proc Natl Acad Sci U S A , vol.93 , pp. 4851-4856
    • Robinson, G.S.1    Pierce, E.A.2    Rook, S.L.3
  • 76
    • 0028786651 scopus 로고
    • Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGFreceptor chimeric proteins
    • Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGFreceptor chimeric proteins. Proc Natl Acad Sci U S A. 1995;92:10457-10461.
    • (1995) Proc Natl Acad Sci U S A , vol.92 , pp. 10457-10461
    • Aiello, L.P.1    Pierce, E.A.2    Foley, E.D.3
  • 77
    • 0035956869 scopus 로고    scopus 로고
    • Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor
    • Stellmach V, Crawford SE, ZhouW, et al. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A. 2001;98:2593-2597.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 2593-2597
    • Stellmach, V.1    Crawford, S.E.2    Zhou, W.3
  • 78
    • 67749086523 scopus 로고    scopus 로고
    • Antivascular endothelial growth factor for retinopathy of prematurity
    • Mintz-Hittner HA, Best LM. Antivascular endothelial growth factor for retinopathy of prematurity. Curr Opin Pediatr. 2009;21:182-187.
    • (2009) Curr Opin Pediatr , vol.21 , pp. 182-187
    • Mintz-Hittner, H.A.1    Best, L.M.2
  • 80
    • 47749100480 scopus 로고    scopus 로고
    • Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone i or posterior zone II
    • Mintz-Hittner HA, Kuffel RR. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina. 2008;28:831-838.
    • (2008) Retina , vol.28 , pp. 831-838
    • Mintz-Hittner, H.A.1    Kuffel, R.R.2
  • 81
    • 77749279443 scopus 로고    scopus 로고
    • Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity
    • Law JC, Recchia FM, Morrison DG, et al. Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J AAPOS. 2010;14:6-10.
    • (2010) J AAPOS , vol.14 , pp. 6-10
    • Law, J.C.1    Recchia, F.M.2    Morrison, D.G.3
  • 82
    • 34848909008 scopus 로고    scopus 로고
    • Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone i retinopathy of prematurity
    • Chung EJ, Kim JH, Ahn HS, et al. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2007;245:1727-1730.
    • (2007) Graefes Arch Clin Exp Ophthalmol , vol.245 , pp. 1727-1730
    • Chung, E.J.1    Kim, J.H.2    Ahn, H.S.3
  • 83
    • 0034895201 scopus 로고    scopus 로고
    • Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity
    • Chowers I, Banin E, Hemo Y, et al. Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity. Br J Ophthalmol. 2001;85: 991-995.
    • (2001) Br J Ophthalmol , vol.85 , pp. 991-995
    • Chowers, I.1    Banin, E.2    Hemo, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.